EGFR and lung cancer: In view of its promising therapeutic potential in EGFR-mutated metastatic lung cancer, several scholars have started to use targeted therapy for early resectable EGFR-mutated lung cancer in the neoadjuvant setting Xiong et al., 2019; Zhang et al., 2021).